When a sharp, stabbing stomach pain hit 39-year-old Krystal Maeyke, she attributed it to an allergy or working too hard as a mom. Active, healthy, and fit, the mother of one did not think of herself as vulnerable to cancer—until symptoms could no longer be denied.

Three months after that, Maeyke was diagnosed with stage 4 metastatic bowel cancer, a fact that put her world into disarray and is now a warning to young adults around the world: cancer doesn't care how fit or healthy you look or feel. Even though she was "super healthy and fit," Krystal's experience is a wake-up call that cancer doesn't discriminate on the basis of age, fitness, or family history. Her experience, honestly filmed on TikTok, is now prompting tens of thousands to see and respond to the tricky, much-misunderstood signs of bowel cancer.

Krystal's nightmare started with what she thought were harmless symptoms—sharp, stabbing pains in the lower abdomen. Similar to many, she credited them to an assumed food allergy or irritable bowel syndrome (IBS), particularly given that she was otherwise healthy and had no history of cancer in her family. For three months, she dismissed the discomfort as a result of the demands of motherhood and an active lifestyle. But the symptoms didn't end there. Krystal remembers having:

Recurring, inexplicable night sweats: So bad that she would wake up soaked, having to change clothes and sheets several times throughout the night.

Chronic fatigue: She was exhausted all day, all the time, but wrote it off as the unavoidable exhaustion of being a working mom.

Loss of appetite and abnormal bowel habits: She experienced changes in digestion, but attributed them to diet or stress.

General malaise: A sense of illness that she couldn't put her finger on.

These signs, she later discovered, were the classic prodrome of bowel cancer. But since they were mild, non-specific, and readily explainable by less serious causes, Krystal—like many others—dismissed them until the pain was excruciating.

"I was experiencing stabbing pains, very fatigued, night sweats, loss of appetite, spastic bowel movements, and just off in general," she explained in an open TikTok video chronicling her diagnosis. Like many others, she wrote it off as stress, a busy life, and maybe food intolerance.

She had never thought that these symptoms might be indicative of something potentially deadly.

Some evenings I would wake up sweating and need to change my clothes and bedding. But it was summer, and I had the air conditioner on, so I figured the room wasn't cold enough.

The turning point came when Krystal’s pain reached an intensity she could no longer manage. Living in the remote Australian desert town of Yulara, she was airlifted 280 miles by the Royal Flying Doctors Service to Alice Springs Hospital. There, a battery of tests revealed the unthinkable: stage four metastatic bowel cancer. The cancer had spread beyond her bowel to her abdomen, liver, and ovaries.

Krystal remembers the incident clearly, "I was awoken later that night by a doctor whose words I will never forget. 'Krystal, I've got bad news… You have cancer.' The gravity of those words, coupled with my question of 'How do you know?' and the doctor's reply, 'It's everywhere,' shook me to my core."

What is Advanced Bowel Cancer?

Stage four, or metastatic, colorectal cancer implies the disease has invaded distant organs. The Cleveland Clinic describes this as the most advanced and hardest-to-treat stage. Krystal's case is not unusual: many patients, particularly younger ones, are diagnosed late because early signs are indistinct or mistaken for less severe conditions.

Krystal's case highlights an important reality: bowel cancer can develop and spread viciously, even for those who look reasonably healthy. She experienced every stabbing pain as the tumour developed, almost clogging her bowels, and subsequently noticed a lump she was aware of was not an innocent lymph node, but a tumour.

I was awakened by a doctor whose words I'll never forget," she said. "'Krystal, I've got bad news… You have cancer.' When I asked him how he knew, he said, 'It's everywhere.'

Stage 4 bowel cancer, or metastatic colorectal cancer, is when the cancer has spread to other parts of the body away from the colon or rectum—usually to the liver, lungs, or ovaries. In Krystal's situation, tumors were located throughout her abdomen, liver, ovaries, and bowel. She suspects the constant stabbing pains were because tumors were compressing the important organs and nerves.

"I could feel each stabbing pain," she said. "The tumor was halfways blocking my bowels. I could feel the lump, which they informed me could be merely a lymph node—it was the tumor. And then I could feel it reach my ovaries."

Why Are Younger People at Risk?

A recent study by Cancer Research UK and international studies have pointed to a concerning trend: bowel cancer diagnoses are increasing among individuals under the age of 50. For 27 of 50 countries, cases of early-onset have grown, with young adults diagnosed 23% more in some age brackets. The recent passing of social media personality Tanner Martin at the age of 30 has further focused attention on this concerning trend.

What is perhaps most shocking about Maeyke's story is how many of her symptoms are so typical, non-threatening complaints—tiredness, irregular bowel movements, night sweats that occur with the rise in temperature. With no known family history of cancer, exercising regularly and having a well-balanced diet, she had every reason to assume she was healthy.

But as Krystal's case highlights, bowel cancer is striking younger and younger adults, and the initial symptoms are usually not recognized or misdiagnosed.

Krystal's case is an impassioned plea to act. If you have persistent, unexplained symptoms—most importantly, abdominal pain, night sweats, or alteration in bowel habits—do not brush them aside. Seek advice from a doctor and push for extensive testing if symptoms remain.

Early diagnosis is key: although only slightly more than half of bowel cancer sufferers live 10 years after diagnosis, prognosis is so much better if the disease is diagnosed early. Screening and knowing the symptoms can help save lives.

In the United States, the second most common cause of cancer mortality, colorectal cancer, has seen its diagnoses in people below 50 years surge dramatically over the past few years. Scientists are yet to figure out why—citing processed food, inactive lifestyles, environmental pollutants, and even microplastic exposure as probable culprits.

The passing of 30-year-old influencer Tanner Martin from colon cancer last year pushed the issue further to the forefront, prompting discussions around early screening and education.

Recognising Symptoms of Bowel Cancer

The symptoms of bowel cancer may be challenging to identify in its early stages, Cancer Research UK and the Cleveland Clinic say. Some common symptoms include:

• Rectal bleeding or blood in the stool
• Changes in bowel movements (constipation or diarrhea)
• Fatigue or shortness of breath
• Abdominal pain or bloating
• Unexplained weight loss
• A lump in the abdomen

Yet, many patients show no symptoms until the cancer has already progressed—underscoring the need for vigilance and proactive screening.

Since her diagnosis, Krystal has undergone multiple rounds of chemotherapy and shares her cancer journey with over 50,000 TikTok followers, aiming to raise awareness and offer support to others facing similar battles.

One of her biggest worries, she says, isn't the disease itself—but the psychological cost on her young son, Maison.

"He longs for my warmth, my guidance, and my love—a love that cancer is stealing away," she wrote in a heartbreaking post.

But she's still dedicated to raising awareness. Her tip: "Take symptoms seriously. Night sweats, pain, fatigue—don't ignore them. Trust your instincts. Early detection might just save your life."

If menopause had a social media profile, its relationship status with women’s health would be… “complicated”. Sure, the hot flashes and mood swings grab most of the headlines, but lurking quietly in the background is another issue: bone loss. Oestrogen is important when it comes to keeping bones strong. Once its levels dip during menopause, women become much more prone to osteoporosis.”

Why Oestrogen Is Crucial

Bone is a living tissue that constantly rebuilds and repairs itself. Oestrogen is what keeps this construction site running smoothly. “When oestrogen drops, the balance between bone building and bone breakdown collapses,” explains Dr. Pramila Kalra, Consultant, Department of Endocrinology, Ramaiah Memorial Hospital. This leads to bones that weaken faster than they can repair.

And it’s not just an invisible problem on a scan. Weakened bones translate into fractures from the most minor of falls. Hips, spines, and wrists are the usual casualties. “To put it into perspective, women over 50 face a 15% lifetime risk of hip fracture, and recovering from one can seriously affect independence,” says Dr. Kalra.

Understanding Hormone Replacement Therapy (HRT)

“HRT replaces the hormones your body no longer produces enough of after menopause, and this can significantly slow down bone loss,” says Dr. Kalra. Not only does it help bones maintain their density, but in some cases, it can even nudge bone strength upwards.

HRT isn’t a one-size-fits-all pill. It comes in forms that suit different lifestyles: tablets, patches, gels, and even sprays. For women with a uterus, progesterone usually joins the prescription party to protect the uterine lining. And along with stronger bones, many women also notice relief from hot flashes, night sweats, and that infamous menopause brain fog.

Is HRT Right for You?

Before you rush to the pharmacy, there are questions worth asking. “HRT works best for women who have severe menopausal symptoms or are at a high risk of osteoporosis,” says Dr. Kalra. Women who experience early menopause, particularly before age 45, are often strong candidates for HRT because their bones face years of oestrogen shortfall.

Safety concerns around HRT have caused plenty of headlines in the past. But newer research has changed the conversation. “When HRT is started within 10 years of menopause and before age 60, the benefits outweigh the risks for most women,” explains Dr. Kalra.

Still, the risks are not zero. There may be a slight increase in the chance of blood clots or breast cancer depending on personal health, the type of HRT, and how long it’s used. “That’s why an individualised discussion with your doctor is crucial. It’s about weighing your personal benefits against possible risks,” she stresses.

A Bigger Bone Health Plan

Dr. Kalra recommends thinking beyond medication. A diet rich in calcium and vitamin D, regular exercise—particularly weight-bearing workouts—and avoiding smoking and excessive alcohol are all essential. “HRT is most effective as part of a holistic bone health plan,” she says.

The Need for Personalised Care

There’s no “universal prescription” for menopause management. “The decision to start HRT must be highly individualised,” advises Dr. Kalra. Your doctor will consider your family history, existing health conditions, and results from a bone density scan. Together, you can discuss the type, dose, and duration of therapy that best fits your needs.

The conversation should cover not just symptoms but also your future risks. “It’s not about erasing menopause—it’s about empowering women to make informed choices so they can stay active and independent for years to come,” says Dr. Kalra.

Menopause may be inevitable, but brittle bones don’t have to be. With the right support, including HRT where appropriate, women can safeguard their bone health and dramatically reduce their risk of fractures. “Think of it as investing in your future mobility and independence,” Dr. Kalra concludes.

Autism is often painted as a childhood condition, usually spotted in the school playground when social quirks or communication differences raise eyebrows. But what happens when those children grow up without anyone connecting the dots? According to new research from King’s College London, the answer is unsettling: most autistic adults over 40 are still flying under the diagnostic radar.

The review, published in the Annual Review of Developmental Psychology, estimates that a staggering 89 per cent of people over 40 with autism remain undiagnosed. To put that into perspective, while around 23 per cent of autistic children under 19 are missed, nearly 96 per cent of those over 60 have never been recognised as autistic. That’s not just a gap; that’s a canyon.

The Age Factor

When the researchers broke it down by age and gender, the numbers looked even more lopsided. Among men aged 40 to 59, more than 91 per cent had never been diagnosed. For women in the same age group, the figure was almost 80 per cent. By the time people reached their sixties, both men and women crossed into the 96 to 97 per cent range of being undiagnosed.

Compare that with the 20 to 39 age group, where roughly half remained undiagnosed, and the generational divide becomes clear. Today’s younger adults are far more likely to be spotted, assessed and supported. Older adults, meanwhile, have often been left to muddle through without a name for their lifelong differences.

Why It Matters

Gavin Stewart, lead author of the study, explains that a lack of diagnosis means many autistic adults were never offered the right support, leaving them more vulnerable to age-related problems. These range from social isolation to poor physical and mental health.

The review found that autistic people in middle age and beyond have higher rates of almost every health condition compared to non-autistic peers, like heart disease, neurological issues, autoimmune disorders, gastrointestinal problems, anxiety and depression. Add age-related conditions like osteoporosis, arthritis and Parkinson’s disease, and the picture gets even more complicated.

Even more concerning, autistic older adults were six times more likely to report suicidal thoughts or self-harm and four times more likely to develop early-onset dementia.

The Hidden Struggles

The study highlighted another layer of challenge: healthcare itself. Many older autistic adults face obstacles in accessing medical support due to communication differences, sensory sensitivities or simply not knowing how to navigate the system. Combine that with a shortage of healthcare professionals trained in recognising autism in adults, and it’s no wonder so many cases slip through the cracks.

Professor Francesca Happé, co-author of the review, stresses that this is a global public health issue. “Understanding the needs of autistic people as they age is a pressing global public health concern. As autistic people age, the nature of the challenges they face changes. We must adopt a lifespan approach that funds long-term research, integrates tailored healthcare, and expands social supports so that ageing autistic people can live happy and healthy lives,” she says. In other words, autism doesn’t disappear after childhood, so neither should support.

Lost in the Shuffle

The findings also suggest that research into autism may have been skewed for years. If most older adults remain undiagnosed, then studies have largely overlooked them. That means our current understanding of how autistic people age is incomplete at best. No wonder policies and services have not caught up.

Employment struggles, strained relationships and social isolation were all noted as common experiences for older autistic adults. Without the framework of a diagnosis, many never knew why they felt out of step with the world, and their difficulties were often chalked up to personality flaws or “just how they are”.

Why a Diagnosis Still Matters

If you’re wondering whether getting a diagnosis later in life makes a difference, the answer is yes. Recognition can bring clarity, opening doors to support systems, healthcare adaptations and even financial benefits. It can also reshape how family, friends and colleagues understand a person’s behaviour and needs.

The NHS encourages adults who suspect they might be autistic to speak to their GP and ask about a referral for an assessment. Specialists can help by gathering life history, speaking with people who know you well and observing how you interact with others.

A Call for Change

The review ends with a clear message: it’s time to stop treating autism as a childhood-only issue. For too long, older autistic adults have been invisible, their experiences untold and their needs unmet. With diagnosis rates still alarmingly low, researchers are urging more studies, better services and a cultural shift that embraces autism across the lifespan.

When blockbuster diabetes drugs double as miracle weight-loss injections, it seems like everyone wants in. But now, the same medications are making headlines for possible vision loss.

The Double Life of GLP-1 Drugs

Originally designed to regulate blood sugar in type 2 diabetes, GLP-1 receptor agonists, which cover Ozempic, Mounjaro, Wegovy, Trulicity, Rybelsus and others, quickly became famous in the weight-loss world. Social media crowned them the “skinny jab”, while pharmaceutical companies rushed out new versions to keep up with demand.

But as prescriptions soared, so did reports of odd side effects. Stomach paralysis (gastroparesis), intestinal blockages and now a rare vision condition are creeping into the conversation. It turns out shedding pounds might come with strings attached, ones that affect more than your waistline.

A Shadow on the Horizon: NAION

The latest condition in this story is nonarteritic anterior ischaemic optic neuropathy, or NAION for short. It is a mouthful, but the condition itself is no joke. NAION can blur vision permanently or even lead to blindness by damaging the optic nerve.

Whispers of this link first appeared in mid-2024, when Harvard researchers published a study claiming Ozempic users faced a seven-fold higher risk of NAION compared to non-users. Just weeks later, another paper in JAMA Ophthalmology suggested the concern was not limited to Ozempic; it was likely an issue across the entire GLP-1 family.

What the Experts Are Saying

Researchers point out that while there is a measurable increase in eye complications, the story isn’t as clear-cut as it sounds.

A recent retrospective study found a slight but significant uptick, about 7 per cent, in new cases of diabetic retinopathy (DR) among GLP-1 users. DR is a common complication of diabetes itself, where blood vessels in the retina become damaged. Interestingly, though, these same patients did not show a higher risk of progressing to severe complications like proliferative retinopathy or diabetic macular oedema.

Reports suggest that patients on GLP-1 drugs should be screened regularly for eye problems, no matter their baseline status. In other words, keep your ophthalmologist on speed dial.

From Courtrooms to Clinics

While doctors debate the data, lawyers are already busy. Eli Lilly, maker of Mounjaro and Zepbound, has asked federal judges to consolidate the growing pile of lawsuits into one massive multidistrict litigation (MDL). This would lump together claims of optic nerve damage with the thousands of cases already filed over gastroparesis.

The lawsuits accuse manufacturers of pushing profits over patient safety, alleging that the risks of vision loss were downplayed or overlooked. With more patients joining the legal fray, the story is no longer confined to medical journals; it is unfolding in courtrooms across the US.

The Balancing Act for Patients

For people with type 2 diabetes, GLP-1 drugs remain highly effective. They lower blood sugar, help with weight loss, and even offer some protection against heart disease. For many, the benefits still outweigh the risks.

But the newfound spotlight on NAION is a reminder that no drug is without trade-offs. Those weekly injections may slim waistlines, but they also highlight the need for vigilance. Patients should discuss eye health with their doctors, schedule regular check-ups, and report any sudden changes in vision immediately.